Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 2/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 1/20 | 0.33 |
| ▸ | ADH1B | P00325 | 1/20 | 0.33 |
| ▸ | ADH1C | P00326 | 1/20 | 0.33 |
| ▸ | ADH1A | P07327 | 1/20 | 0.33 |
| ▸ | ADH4 | P08319 | 1/20 | 0.33 |
| ▸ | ADH7 | P40394 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3099299 | 0.95 | TSHR (0.46) | TSHRALDH1A1CYP3A4SMN1; SMN2TDP1 | |
| SCHEMBL276625 | 0.93 | LMNA (0.43) | TSHRALDH1A1CYP3A4SMN1; SMN2LMNA | |
| SCHEMBL9263689 | 0.91 | LMNA (0.46) | TSHRLMNAFAAHTRPV1ADH1B | |
| SCHEMBL2961306 | 0.91 | LMNA (0.46) | TSHRLMNAFAAHTRPV1ADH1B | |
| SCHEMBL3850489 | 0.91 | LMNA (0.46) | TSHRLMNAFAAHTRPV1ADH1B | |
| SCHEMBL3841827 | 0.91 | LMNA (0.46) | TSHRLMNAFAAHTRPV1ADH1B | |
| SCHEMBL3847166 | 0.91 | LMNA (0.46) | TSHRLMNAFAAHTRPV1ADH1B | |
| SCHEMBL7733731 | 0.91 | LMNA (0.46) | TSHRLMNAFAAHTRPV1ADH1B | |
| SCHEMBL11030873 | 0.90 | TSHR (0.46) | TSHRALDH1A1CYP3A4SMN1; SMN2TDP1 | |
| SCHEMBL3844336 | 0.90 | ALDH1A1 (0.38) | TSHRALDH1A1CYP3A4SMN1; SMN2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5831135-A | CATALYST SELECTIVITY; PURITY | HUELS AKTIENGESELLSCHAFT (DE) | 1998-11-03 | — | — | US | claimed |
| US-5675045-A | Process for the catalytic selective hydrogenation of polyunsaturated organic substances | HUELS AKTIENGESELLSCHAFT (DE) | 1997-10-07 | — | — | US | claimed |
| EP-0753496-A2 | Process for the catalytic selective hydrogenation of multiple unsaturated organic substances | HÜLS AKTIENGESELLSCHAFT (DE) | 1997-01-15 | — | — | EP | claimed |
| US-20230406801-A1 | PROCESSES TO IMPROVE CATALYTIC METAL ACCOUNTABILITY IN HYDROFORMYLATION PROCESSES | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2023-12-21 | — | — | US | disclosed |
| EP-4259598-A1 | PROCESSES TO IMPROVE CATALYTIC METAL ACCOUNTABILITY IN HYDROFORMYLATION PROCESSES | Dow Technology Investments LLC (US) | 2023-10-18 | — | — | EP | disclosed |
| CN-116635362-A | Method for improving the metering of catalytic metals in hydroformylation processes | 陶氏技术投资有限责任公司 | 2023-08-22 | — | — | CN | disclosed |
| WO-2022132372-A1 | PROCESSES TO IMPROVE CATALYTIC METAL ACCOUNTABILITY IN HYDROFORMYLATION PROCESSES | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2022-06-23 | — | — | WO | disclosed |
| WO-2017048956-A1 | NUCLEOTIDE ANALOGS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-03-23 | — | — | WO | disclosed |
| US-5998635-A | CATALYTIC CYCLIZATION AN ALDEHYDE WITH A KETENE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1999-12-07 | — | — | US | disclosed |
| US-5831135-A | CATALYST SELECTIVITY; PURITY | HUELS AKTIENGESELLSCHAFT (DE) | 1998-11-03 | — | — | US | disclosed |
| US-5675045-A | Process for the catalytic selective hydrogenation of polyunsaturated organic substances | HUELS AKTIENGESELLSCHAFT (DE) | 1997-10-07 | — | — | US | disclosed |
| EP-0753496-A2 | Process for the catalytic selective hydrogenation of multiple unsaturated organic substances | HÜLS AKTIENGESELLSCHAFT (DE) | 1997-01-15 | — | — | EP | disclosed |
| US-5072057-A | Isomeric alcohol mixture for producing plasticizers and surfac tants | EXXON RESEARCH & ENGINEERING CO. (US) | 1991-12-10 | — | — | US | disclosed |
| US-5030774-A | Reacting petroleum distillates with carbon monoxide and hydrogen to form aldehyde in presence of carbonyl compounds hydrogenation to form alcohols | EXXON RESEARCH AND ENGINEERING CO. (US) | 1991-07-09 | — | — | US | disclosed |
| EP-0329670-A1 | A PROCESS FOR THE HYDROFORMYLATION OF SULFUR-CONTAINING THERMALLY CRACKED PETROLEUM RESIDUA AND NOVEL PRODUCTS THEREOF. | EXXON RESEARCH ENGINEERING CO (US) | 1989-08-30 | — | — | EP | disclosed |
| EP-0329670-A4 | A PROCESS FOR THE HYDROFORMYLATION OF SULFUR-CONTAINING THERMALLY CRACKED PETROLEUM RESIDUA AND NOVEL PRODUCTS THEREOF. | EXXON RESEARCH ENGINEERING CO (US) | 1989-08-16 | — | — | EP | disclosed |
| WO-1988002360-A1 | A PROCESS FOR THE HYDROFORMYLATION OF SULFUR-CONTAINING THERMALLY CRACKED PETROLEUM RESIDUA AND NOVEL PRODUCTS THEREOF | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1988-04-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230406801-A1 | PROCESSES TO IMPROVE CATALYTIC METAL ACCOUNTABILITY IN HYDROFORMYLATION PROCESSES | RTF1, PYM1, CYP4F11 | TSHR 2999/4885ALDH1A1 2462/4885CYP3A4 1107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.